FP405EFFICACY AND SAFETY OF SEVELAMER CARBONATE IN HYPERPHOSPHATEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE ON HEMODIALYSIS AND NON-DIALYSIS: A PROSPECTIVE, OPEN-LABEL, DOSE-TITRATION STUDY IN RUSSIA | Zendy

AI Assistant Blog Pricing

FP405EFFICACY AND SAFETY OF SEVELAMER CARBONATE IN HYPERPHOSPHATEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE ON HEMODIALYSIS AND NON-DIALYSIS: A PROSPECTIVE, OPEN-LABEL, DOSE-TITRATION STUDY IN RUSSIA

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.